Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention

Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention

Alzheimer’s disease (AD) is a neurodegenerative dementia that affects nearly 50 million people worldwide and is a major source of morbidity, mortality, and healthcare expenditure. While there have been many attempts to develop disease-modifying therapies for late-onset AD, none have so far shown eff...

Full description

Bibliographic Details
Main Authors: Matthew W. Schelke, Peter Attia, Daniel J. Palenchar, Bob Kaplan, Monica Mureb, Christine A. Ganzer, Olivia Scheyer, Aneela Rahman, Robert Kachko, Robert Krikorian, Lisa Mosconi, Richard S. Isaacson
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer’s disease
Alzheimer’s prevention
clinical precision medicine
precision medicine
glucose hypometabolism
inflammation
Online Access:http://journal.frontiersin.org/article/10.3389/fnagi.2018.00096/full

Internet

http://journal.frontiersin.org/article/10.3389/fnagi.2018.00096/full

Similar Items